4.7 Review

Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions

Journal

CELL STEM CELL
Volume 18, Issue 1, Pages 53-65

Publisher

CELL PRESS
DOI: 10.1016/j.stem.2015.12.002

Keywords

-

Funding

  1. MGH Collaborative Center for X-linked Dystonia-Parkinsonism
  2. NIH [U01HL100408, U01HL107440, R01DK095384, R01DK097768]
  3. Harvard Stem Cell Institute

Ask authors/readers for more resources

Human pluripotent stem cells (hPSCs) with knockout or mutant alleles can be generated using custom-engineered nucleases. Transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 nucleases are the most commonly employed technologies for editing hPSC genomes. In this Protocol Review, we provide a brief overview of custom-engineered nucleases in the context of gene editing in hPSCs with a focus on the application of TALENs and CRISPR/Cas9. We will highlight the advantages and disadvantages of each method and discuss theoretical and technical considerations for experimental design.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available